๐บ๐ธ ๋ฏธ๊ตญ ยท "MEDICINES" ยท ์ด 7๊ฑด
ํํฐ ๋ณด๊ธฐํ์ฌ ์ง์
50.0
0 = ๋ถ์ ์ฐ์ธ
50 = ์ค๋ฆฝ
100 = ๊ธ์ ์ฐ์ธ
์ต๊ทผ 7์ผ ๊ธฐ์ค 11,884๊ฑด์ ๋ถ์ํ ๊ฒฐ๊ณผ, ๋ด์ค ์ฌ๋ฆฌ์ง์๋ 50.0(๊ท ํ)์ ๋๋ค. ๊ธ์ 1๊ฑด(0.0%)ยท์ค๋ฆฝ 11,882๊ฑด(100.0%)ยท๋ถ์ 1๊ฑด(0.0%)์ด๋ฉฐ, ์ค๋ฆฝ ๋น์ค์ด ๋๋ ทํ๊ฒ ๋์ต๋๋ค. ์ฑํฅ ์ง์๋ ์ข ํฉ 18.8(์ค๋ ๊ท ํ)์ ๋๋ค.
AstraZeneca CEO Pascal Soriot said AI is helping the company develop medicines faster and make smarter decisions throughout the research process.
Most adult Americans take at least one prescription drug, and for too many, getting that prescription filled means battling the very system thatโs supposed to help them. Insurance denials have become alarmingly routine. A recent study found that 70% of commercially insured patients face initial claim rejections for new branded medicines. And even when patients [โฆ]
The Supreme Court will soon decide a case that could upend the balance built into a bipartisan law that has accelerated the launch of generic drugs and saved American patients, employers, and taxpayers trillions of dollars in recent decades โ while still incentivizing biopharmaceutical companies to research and develop medicines in the first place. The [โฆ]
More than 1 in 10 U.S. adults is currently taking a GLP-1 weight-loss drug. And these medicines are getting cheaper seemingly by the day. Since Wegovy launched, its list price has fallen from roughly $1,300 per month to between $300 and $500 per month. Similarly, Zepbound was once about $1,000 per month, but it now [โฆ]
Treasury Secretary Scott Bessent will deliver a speech at the Reagan National Economic Forum on Friday warning that decades of U.S. industrial policy have left the country strategically vulnerable. During a talk titled "While America Slept," Bessent will argue that policymakers have sought efficiency over resilience, hollowing out productive capacity in semiconductors, rare earths, medicines...
Innovent Biologics rose as much as 10%, after entering a strategic global licensing and collaboration agreement with Pfizer to develop oncology medicines.
The measure, which goes against the guidance by the World Health Organization, underscores growing fears of contagion in East Africa from Bundibugyo, a rare type of the Ebola virus that is behind this outbreak and that has no approved medicines or vaccines.